Evidence map›Paper›PMID 24581739›Full record

ArticleAmerican journal of human genetics2014

An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.

Joan P Breyer, Daniel C Dorset, Travis A Clark, Kevin M Bradley, Tiina A Wahlfors, Kate M McReynolds, William H Maynard, Sam S Chang, Michael S Cookson, Joseph A Smith and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Multifaceted role ofiScience · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Low Expression of Pseudogene POU5F1B Affects Diagnosis and Prognosis in Acute Myeloid Leukemia (AML).Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Joan P BreyerDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Daniel C DorsetDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Travis A ClarkDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Kevin M BradleyDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Foundation for Applied Molecular Evolution, Gainesville, FL 32604, USA.
Tiina A WahlforsInstitute of Biomedical Technology/BioMediTech, University of Tampere, and Fimlab Laboratories, Tampere, 33520, Finland.
Kate M McReynoldsDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
William H MaynardDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Sam S ChangDepartment of Urological Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Michael S CooksonDepartment of Urological Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Joseph A SmithDepartment of Urological Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Johanna SchleutkerDepartment of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Turku, 20014, Finland.
William D DupontDepartment of Biostatistics, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jeffrey R SmithDepartment of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Medical Research Service, Veteran's Affairs Tennessee Valley Healthcare System, Nashville, TN 37212, USA. Electronic address: jeffrey.smith@vanderbilt.edu.
Vanderbilt University · USTampere University · FIUniversity of Turku · FI

Funding

Prostate Cancer Susceptibility: The ICPCG StudyU01CA089600 · NCI · MAYO CLINIC ROCHESTER · PI THIBODEAU, STEPHEN NORMAN · 2002 to 2016
$27.3M
Heritable Risk Factors for Familial Prostate CancerI01BX002502 · VA · VETERANS HEALTH ADMINISTRATION · PI SMITH, JEFFREY R. · 2014 to 2017
–
BLRD VA I01 BX002502NCI NIH HHS U01 CA089600NCI NIH HHS U01 CA89600
6 · The paper itself

Abstract

Genetic association studies of prostate and other cancers have identified a major risk locus at chromosome 8q24. Several independent risk variants at this locus alter transcriptional regulatory elements, but an affected gene and mechanism for cancer predisposition have remained elusive. The retrogene POU5F1B within the locus has a preserved open reading frame encoding a homolog of the master embryonic stem cell transcription factor Oct4. We find that 8q24 risk alleles are expression quantitative trait loci correlated with reduced expression of POU5F1B in prostate tissue and that predicted deleterious POU5F1B missense variants are also associated with risk of transformation. POU5F1 is known to be self-regulated by the encoded Oct4 transcription factor. We further observe that POU5F1 expression is directly correlated with POU5F1B expression. Our results suggest that a pathway critical to self-renewal of embryonic stem cells may also have a role in the origin of cancer.

Indexed as

Gene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseAdolescentAdultAgedAllelesCase-Control StudiesCell NucleusCell Transformation, NeoplasticDatabases, GeneticEmbryonic Stem CellsGenetic VariationGenotypeHaplotypesHumansMaleOctamer Transcription Factor-3POU5F1 protein, human

Identifiers

PMID24581739
PMCPMC3951923
OpenAlexW1989335612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.